We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$13.9B
AUM Growth
-$512M
Cap. Flow
-$427M
Cap. Flow %
-3.07%
Top 10 Hldgs %
13.98%
Holding
2,837
New
70
Increased
591
Reduced
1,041
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 13.1%
2 Financials 12.77%
3 Healthcare 11.82%
4 Energy 11.39%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REX icon
2001
REX American Resources
REX
$1.44B
$332K ﹤0.01%
27,372
OWW
2002
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$332K ﹤0.01%
42,175
WRES
2003
DELISTED
WARREN RESOURCES INC
WRES
$331K ﹤0.01%
62,452
USNA icon
2004
Usana Health Sciences
USNA
$252M
$330K ﹤0.01%
8,964
SFE
2005
DELISTED
Safeguard Scientifics, Inc.
SFE
$330K ﹤0.01%
17,917
AMWD
2006
DELISTED
American Woodmark
AMWD
$329K ﹤0.01%
8,929
STAA icon
2007
STAAR Surgical
STAA
$1.26B
$329K ﹤0.01%
30,964
SYBT icon
2008
Stock Yards Bancorp
SYBT
$2.64B
$328K ﹤0.01%
16,340
CPN
2009
DELISTED
Calpine Corporation
CPN
$328K ﹤0.01%
15,136
+251
+2% +$5.68K
ZSPH
2010
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$328K ﹤0.01%
+8,352
New +$276K
DNKN
2011
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$327K ﹤0.01%
7,295
-55
-0.7% -$2.45K
ALNY icon
2012
Alnylam Pharmaceuticals
ALNY
$30.4B
$326K ﹤0.01%
4,171
-21
-0.5% -$1.35K
UVE icon
2013
Universal Insurance Holdings
UVE
$1.18B
$326K ﹤0.01%
25,194
GST
2014
DELISTED
Gastar Exploration Inc.
GST
$326K ﹤0.01%
55,531
+19,475
+54% +$143K
ENTA icon
2015
Enanta Pharmaceuticals
ENTA
$391M
$325K ﹤0.01%
8,222
GTN icon
2016
Gray Television
GTN
$520M
$325K ﹤0.01%
41,238
RARE icon
2017
Ultragenyx Pharmaceutical
RARE
$2.6B
$325K ﹤0.01%
5,748
-1,511
-21% -$76K
OPCH icon
2018
Option Care Health
OPCH
$3.61B
$324K ﹤0.01%
11,739
RMTI icon
2019
Rockwell Medical
RMTI
$30.9M
$324K ﹤0.01%
322
JRN
2020
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
$324K ﹤0.01%
38,380
MSFG
2021
DELISTED
MainSource Financial Group Inc
MSFG
$324K ﹤0.01%
18,801
HOV icon
2022
Hovnanian Enterprises
HOV
$799M
$323K ﹤0.01%
3,517
OMER icon
2023
Omeros
OMER
$1.26B
$323K ﹤0.01%
25,413
TRC icon
2024
Tejon Ranch
TRC
$443M
$323K ﹤0.01%
11,850
-338
-3% -$9.51K
WTI icon
2025
W&T Offshore
WTI
$546M
$323K ﹤0.01%
29,367

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2014 Portfolio in Review

As of Q3 2014, Metropolitan Life Insurance Company (MetLife) held 2,837 positions worth $13.9B, down 3.6% from $14.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $427M in Q3 2014, closing 180 positions and reducing 1,041 holdings. Its most notable exit was Accenture, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Monsanto Co worth $35.2M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2014 buy was Monsanto Co: 313,199 shares worth $35.2M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q3 2014, an estimated $14M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Accenture in Q3 2014, selling an estimated $31.6M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $13.9B portfolio in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 70 new positions and closed 180 in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 3.6% quarter-over-quarter to $13.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2014, filed 10 Nov 2014.